Literature DB >> 17185462

CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus.

Ling Zhao1, Jennifer L Cannons, Stacie Anderson, Martha Kirby, Liping Xu, Lucio H Castilla, Pamela L Schwartzberg, Rémy Bosselut, P Paul Liu.   

Abstract

Recent studies suggest that the chromosome 16 inversion, associated with acute myeloid leukemia M4Eo, takes place in hematopoietic stem cells. If this is the case, it is of interest to know the effects of the resulting fusion gene, CBFB-MYH11, on other lineages. Here we studied T-cell development in mice expressing Cbfb-MYH11 and compared them with mice compound-heterozygous for a Cbfb null and a hypomorphic GFP knock-in allele (Cbfb(-/GFP)), which had severe Cbfb deficiency. We found a differentiation block at the DN1 stage of thymocyte development in Cbfb-MYH11 knock-in chimeras. In a conditional knock-in model in which Cbfb-MYH11 expression was activated by Lck-Cre, there was a 10-fold reduction in thymocyte numbers in adult thymus, resulting mainly from impaired survival of CD4+CD8+ thymocytes. Although Cbfb-MYH11 derepressed CD4 expression efficiently in reporter assays, such derepression was less pronounced in vivo. On the other hand, CD4 expression was derepressed and thymocyte development was blocked at DN1 and DN2 stages in E17.5 Cbfb(-/GFP) thymus, with a 20-fold reduction of total thymocyte numbers. Our data suggest that Cbfb-MYH11 suppressed Cbfb in several stages of T-cell development and provide a mechanism for CBFB-MYH11 association with myeloid but not lymphoid leukemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185462      PMCID: PMC1852246          DOI: 10.1182/blood-2006-10-051508

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation.

Authors:  Ichiro Taniuchi; Mary Jean Sunshine; Richard Festenstein; Dan R Littman
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

2.  T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage.

Authors:  Laleh Talebian; Zhe Li; Yalin Guo; Justin Gaudet; Maren E Speck; Daisuke Sugiyama; Prabhjot Kaur; Warren S Pear; Ivan Maillard; Nancy A Speck
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

3.  Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.

Authors:  Hong Chang; Rakash Nayar; Dan Li; D Robert Sutherland
Journal:  Cancer Genet Cytogenet       Date:  2005-01-15

Review 4.  Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate.

Authors:  Harald von Boehmer
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

Review 5.  Molecular genetics of T cell development.

Authors:  Ellen V Rothenberg; Tom Taghon
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3.

Authors:  Luke F Peterson; Anita Boyapati; Velvizhi Ranganathan; Atsushi Iwama; Daniel G Tenen; Schickwann Tsai; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

7.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.

Authors:  Joseph D Growney; Hirokazu Shigematsu; Zhe Li; Benjamin H Lee; Jennifer Adelsperger; Rebecca Rowan; David P Curley; Jeffery L Kutok; Koichi Akashi; Ifor R Williams; Nancy A Speck; D Gary Gilliland
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

8.  Dissociation of cytokine signals for proliferation and apoptosis.

Authors:  Y Shi; R Wang; A Sharma; C Gao; M Collins; L Penn; G B Mills
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

9.  Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.

Authors:  Mondira Kundu; Amy Chen; Stacie Anderson; Martha Kirby; LiPing Xu; Lucio H Castilla; David Bodine; Pu Paul Liu
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.

Authors:  Ya-Huei Kuo; Sean F Landrette; Susan A Heilman; Paola N Perrat; Lisa Garrett; Pu P Liu; Michelle M Le Beau; Scott C Kogan; Lucio H Castilla
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 38.585

View more
  12 in total

1.  KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.

Authors:  Ling Zhao; Jan J Melenhorst; Lemlem Alemu; Martha Kirby; Stacie Anderson; Maggie Kench; Shelley Hoogstraten-Miller; Lauren Brinster; Yasuhiko Kamikubo; D Gary Gilliland; P Paul Liu
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

2.  Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

Authors:  Yasuhiko Kamikubo; Ling Zhao; Mark Wunderlich; Takeshi Corpora; R Katherine Hyde; Thomas A Paul; Mondira Kundu; Lisa Garrett; Sheila Compton; Gang Huang; Linda Wolff; Yoshiaki Ito; John Bushweller; James C Mulloy; P Paul Liu
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

Review 3.  Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition.

Authors:  Ya-Huei Kuo; Jing Qi; Guerry J Cook
Journal:  Exp Hematol       Date:  2016-02-26       Impact factor: 3.084

4.  Pentraxin 3 deficiency exacerbates lipopolysaccharide-induced inflammation in adipose tissue.

Authors:  Hong Guo; Xiaoxue Qiu; Jessica Deis; Te-Yueh Lin; Xiaoli Chen
Journal:  Int J Obes (Lond)       Date:  2019-06-17       Impact factor: 5.095

5.  Disruption of Rxra gene in thymocytes and T lymphocytes modestly alters lymphocyte frequencies, proliferation, survival and T helper type 1/type 2 balance.

Authors:  Charles B Stephensen; Alexander D Borowsky; Kevin C Kent Lloyd
Journal:  Immunology       Date:  2007-04-13       Impact factor: 7.397

6.  HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.

Authors:  Jing Qi; Sandeep Singh; Wei-Kai Hua; Qi Cai; Shi-Wei Chao; Ling Li; Hongjun Liu; Yinwei Ho; Tinisha McDonald; Allen Lin; Guido Marcucci; Ravi Bhatia; Wei-Jan Huang; Chung-I Chang; Ya-Huei Kuo
Journal:  Cell Stem Cell       Date:  2015-09-18       Impact factor: 24.633

7.  CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice.

Authors:  Qi Cai; Robin Jeannet; Wei-Kai Hua; Guerry J Cook; Bin Zhang; Jing Qi; Hongjun Liu; Ling Li; Ching-Cheng Chen; Guido Marcucci; Ya-Huei Kuo
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

Review 8.  Core binding factor at the crossroads: determining the fate of the HSC.

Authors:  Kevin A Link; Fu-Sheng Chou; James C Mulloy
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

9.  The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia.

Authors:  H-G Kim; J LeGrand; C S Swindle; H J Nick; R A Oster; D Chen; S Purohit-Ghelani; C V Cotta; R Ko; L Gartland; V Reddy; S W Hiebert; A D Friedman; C A Klug
Journal:  Leukemia       Date:  2017-07-28       Impact factor: 11.528

Review 10.  Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Lucio Hernán Castilla
Journal:  Front Oncol       Date:  2018-04-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.